Orchestra BioMed Holdings Statistics
Total Valuation
OBIO has a market cap or net worth of $234.13 million. The enterprise value is $155.58 million.
Important Dates
The last earnings date was Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OBIO has 59.88 million shares outstanding. The number of shares has increased by 43.90% in one year.
| Current Share Class | 59.88M |
| Shares Outstanding | 59.88M |
| Shares Change (YoY) | +43.90% |
| Shares Change (QoQ) | +1.22% |
| Owned by Insiders (%) | 2.72% |
| Owned by Institutions (%) | 21.11% |
| Float | 33.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.15 |
| Forward PS | 160.08 |
| PB Ratio | 5.66 |
| P/TBV Ratio | 5.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.03, with a Debt / Equity ratio of 0.31.
| Current Ratio | 7.03 |
| Quick Ratio | 6.90 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.04 |
Financial Efficiency
Return on equity (ROE) is -161.12% and return on invested capital (ROIC) is -68.62%.
| Return on Equity (ROE) | -161.12% |
| Return on Assets (ROA) | -43.02% |
| Return on Invested Capital (ROIC) | -68.62% |
| Return on Capital Employed (ROCE) | -63.20% |
| Weighted Average Cost of Capital (WACC) | 7.56% |
| Revenue Per Employee | $380,512 |
| Profits Per Employee | -$638,674 |
| Employee Count | 86 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 0.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.54% in the last 52 weeks. The beta is 0.52, so OBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +32.54% |
| 50-Day Moving Average | 4.19 |
| 200-Day Moving Average | 3.88 |
| Relative Strength Index (RSI) | 44.53 |
| Average Volume (20 Days) | 259,963 |
Short Selling Information
The latest short interest is 842,294, so 1.41% of the outstanding shares have been sold short.
| Short Interest | 842,294 |
| Short Previous Month | 972,590 |
| Short % of Shares Out | 1.41% |
| Short % of Float | 2.51% |
| Short Ratio (days to cover) | 3.76 |
Income Statement
In the last 12 months, OBIO had revenue of $32.72 million and -$54.93 million in losses. Loss per share was -$1.02.
| Revenue | 32.72M |
| Gross Profit | 32.55M |
| Operating Income | -54.96M |
| Pretax Income | -54.64M |
| Net Income | -54.93M |
| EBITDA | -54.63M |
| EBIT | -54.96M |
| Loss Per Share | -$1.02 |
Full Income StatementBalance Sheet
The company has $94.40 million in cash and $15.85 million in debt, with a net cash position of $78.55 million or $1.31 per share.
| Cash & Cash Equivalents | 94.40M |
| Total Debt | 15.85M |
| Net Cash | 78.55M |
| Net Cash Per Share | $1.31 |
| Equity (Book Value) | 50.97M |
| Book Value Per Share | 0.70 |
| Working Capital | 82.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$54.52 million and capital expenditures -$561,000, giving a free cash flow of -$55.08 million.
| Operating Cash Flow | -54.52M |
| Capital Expenditures | -561,000 |
| Depreciation & Amortization | 334,000 |
| Net Borrowing | 20.00M |
| Free Cash Flow | -55.08M |
| FCF Per Share | -$0.92 |
Full Cash Flow StatementMargins
Gross margin is 99.46%, with operating and profit margins of -167.96% and -166.96%.
| Gross Margin | 99.46% |
| Operating Margin | -167.96% |
| Pretax Margin | -166.96% |
| Profit Margin | -166.96% |
| EBITDA Margin | -166.94% |
| EBIT Margin | -167.96% |
| FCF Margin | n/a |
Dividends & Yields
OBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.90% |
| Shareholder Yield | -43.90% |
| Earnings Yield | -23.46% |
| FCF Yield | -23.52% |
Analyst Forecast
The average price target for OBIO is $12.29, which is 214.32% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.29 |
| Price Target Difference | 214.32% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 28.64% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
